FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3097795969> ?p ?o ?g. }

• W3097795969 endingPage "937" @default.
• W3097795969 startingPage "928" @default.
• W3097795969 abstract "PurposeTo review the literature on the efficacy and safety of medical and surgical interventions for indirect traumatic optic neuropathy (TON), defined as injury to the nerve that occurs distal to the optic nerve head.MethodsA literature search was conducted on October 22, 2019, and updated on April 8, 2020, in the PubMed database for English language original research that assessed the effect of various interventions for indirect TON. One hundred seventy-two articles were identified; 41 met the inclusion criteria outlined for assessment and were selected for full-text review and abstraction. On full-text review, a total of 32 studies met all of the study criteria and were included in the analysis.ResultsNo study met criteria for level I evidence. Seven studies (1 level II study and 6 level III studies) explored corticosteroid therapy that did not have uniformly better outcomes than observation. Twenty studies (3 level II studies and 17 level III studies) assessed optic canal decompression and the use of corticosteroids. Although visual improvement was noted after decompression, studies that directly compared surgery with medical therapy did not report uniformly improved outcomes after decompression. Four studies (1 level II study and 3 level III studies) evaluated the use of erythropoietin. Although initial studies demonstrated benefit, a direct comparison of its use with observation and corticosteroids failed to confirm the usefulness of this medication. One study (level II) documented visual improvement with levodopa plus carbidopa. Complication rates were variable with all of these interventions. Pharmacologic interventions generally were associated with few complications, whereas optical canal decompression carried risks of serious side effects, including hemorrhages and cerebrospinal fluid leakage.ConclusionsDespite reports of visual improvement with corticosteroids, optic canal decompression, and medical therapy for indirect TON, the weight of published evidence does not demonstrate a consistent benefit for any of these interventions. In summary, no consensus exists from studies published to date on a preferred treatment for TON. Treatment strategies should be customized for each individual patient. More definitive treatment trials will be needed to identify optimal treatment strategies for indirect TON. To review the literature on the efficacy and safety of medical and surgical interventions for indirect traumatic optic neuropathy (TON), defined as injury to the nerve that occurs distal to the optic nerve head. A literature search was conducted on October 22, 2019, and updated on April 8, 2020, in the PubMed database for English language original research that assessed the effect of various interventions for indirect TON. One hundred seventy-two articles were identified; 41 met the inclusion criteria outlined for assessment and were selected for full-text review and abstraction. On full-text review, a total of 32 studies met all of the study criteria and were included in the analysis. No study met criteria for level I evidence. Seven studies (1 level II study and 6 level III studies) explored corticosteroid therapy that did not have uniformly better outcomes than observation. Twenty studies (3 level II studies and 17 level III studies) assessed optic canal decompression and the use of corticosteroids. Although visual improvement was noted after decompression, studies that directly compared surgery with medical therapy did not report uniformly improved outcomes after decompression. Four studies (1 level II study and 3 level III studies) evaluated the use of erythropoietin. Although initial studies demonstrated benefit, a direct comparison of its use with observation and corticosteroids failed to confirm the usefulness of this medication. One study (level II) documented visual improvement with levodopa plus carbidopa. Complication rates were variable with all of these interventions. Pharmacologic interventions generally were associated with few complications, whereas optical canal decompression carried risks of serious side effects, including hemorrhages and cerebrospinal fluid leakage. Despite reports of visual improvement with corticosteroids, optic canal decompression, and medical therapy for indirect TON, the weight of published evidence does not demonstrate a consistent benefit for any of these interventions. In summary, no consensus exists from studies published to date on a preferred treatment for TON. Treatment strategies should be customized for each individual patient. More definitive treatment trials will be needed to identify optimal treatment strategies for indirect TON." @default.
• W3097795969 created "2020-11-09" @default.
• W3097795969 creator A5001078382 @default.
• W3097795969 creator A5009621636 @default.
• W3097795969 creator A5035474657 @default.
• W3097795969 creator A5036732745 @default.
• W3097795969 creator A5042267117 @default.
• W3097795969 creator A5043137201 @default.
• W3097795969 creator A5070402328 @default.
• W3097795969 creator A5074426568 @default.
• W3097795969 date "2021-06-01" @default.
• W3097795969 modified "2023-10-12" @default.
• W3097795969 title "Interventions for Indirect Traumatic Optic Neuropathy" @default.
• W3097795969 cites W1540015551 @default.
• W3097795969 cites W177333349 @default.
• W3097795969 cites W1965398385 @default.
• W3097795969 cites W1986541813 @default.
• W3097795969 cites W2001890931 @default.
• W3097795969 cites W2008389600 @default.
• W3097795969 cites W2019244271 @default.
• W3097795969 cites W2020580465 @default.
• W3097795969 cites W2028876592 @default.
• W3097795969 cites W2037462205 @default.
• W3097795969 cites W2045759059 @default.
• W3097795969 cites W2065059350 @default.
• W3097795969 cites W2086554526 @default.
• W3097795969 cites W2097388344 @default.
• W3097795969 cites W2336938724 @default.
• W3097795969 cites W2377095624 @default.
• W3097795969 cites W2410004151 @default.
• W3097795969 cites W2646455243 @default.
• W3097795969 cites W2726406569 @default.
• W3097795969 cites W2755221924 @default.
• W3097795969 cites W2762171406 @default.
• W3097795969 cites W2800412425 @default.
• W3097795969 cites W2811043419 @default.
• W3097795969 cites W2884322289 @default.
• W3097795969 cites W2994426291 @default.
• W3097795969 cites W3006957671 @default.
• W3097795969 cites W60168181 @default.
• W3097795969 doi "https://doi.org/10.1016/j.ophtha.2020.10.038" @default.
• W3097795969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33161071" @default.
• W3097795969 hasPublicationYear "2021" @default.
• W3097795969 type Work @default.
• W3097795969 sameAs 3097795969 @default.
• W3097795969 citedByCount "26" @default.
• W3097795969 countsByYear W30977959692021 @default.
• W3097795969 countsByYear W30977959692022 @default.
• W3097795969 countsByYear W30977959692023 @default.
• W3097795969 crossrefType "journal-article" @default.
• W3097795969 hasAuthorship W3097795969A5001078382 @default.
• W3097795969 hasAuthorship W3097795969A5009621636 @default.
• W3097795969 hasAuthorship W3097795969A5035474657 @default.
• W3097795969 hasAuthorship W3097795969A5036732745 @default.
• W3097795969 hasAuthorship W3097795969A5042267117 @default.
• W3097795969 hasAuthorship W3097795969A5043137201 @default.
• W3097795969 hasAuthorship W3097795969A5070402328 @default.
• W3097795969 hasAuthorship W3097795969A5074426568 @default.
• W3097795969 hasConcept C118487528 @default.
• W3097795969 hasConcept C118552586 @default.
• W3097795969 hasConcept C141071460 @default.
• W3097795969 hasConcept C27415008 @default.
• W3097795969 hasConcept C2778233873 @default.
• W3097795969 hasConcept C2779480328 @default.
• W3097795969 hasConcept C2780837183 @default.
• W3097795969 hasConcept C71924100 @default.
• W3097795969 hasConcept C81182388 @default.
• W3097795969 hasConceptScore W3097795969C118487528 @default.
• W3097795969 hasConceptScore W3097795969C118552586 @default.
• W3097795969 hasConceptScore W3097795969C141071460 @default.
• W3097795969 hasConceptScore W3097795969C27415008 @default.
• W3097795969 hasConceptScore W3097795969C2778233873 @default.
• W3097795969 hasConceptScore W3097795969C2779480328 @default.
• W3097795969 hasConceptScore W3097795969C2780837183 @default.
• W3097795969 hasConceptScore W3097795969C71924100 @default.
• W3097795969 hasConceptScore W3097795969C81182388 @default.
• W3097795969 hasFunder F4320312593 @default.
• W3097795969 hasIssue "6" @default.
• W3097795969 hasLocation W30977959691 @default.
• W3097795969 hasOpenAccess W3097795969 @default.
• W3097795969 hasPrimaryLocation W30977959691 @default.
• W3097795969 hasRelatedWork W1479835240 @default.
• W3097795969 hasRelatedWork W2416283517 @default.
• W3097795969 hasRelatedWork W2441192875 @default.
• W3097795969 hasRelatedWork W2900068172 @default.
• W3097795969 hasRelatedWork W2996004571 @default.
• W3097795969 hasRelatedWork W4211081073 @default.
• W3097795969 hasRelatedWork W4236209230 @default.
• W3097795969 hasRelatedWork W603260212 @default.
• W3097795969 hasRelatedWork W79260015 @default.
• W3097795969 hasRelatedWork W2945139785 @default.
• W3097795969 hasVolume "128" @default.
• W3097795969 isParatext "false" @default.
• W3097795969 isRetracted "false" @default.
• W3097795969 magId "3097795969" @default.
• W3097795969 workType "article" @default.